Form D · Pharmaceuticals
MEI Pharma, Inc.
San Diego, CA · CIK 0001262104
Offering snapshot reported May 30, 2018 · SEC filing
- Reported sold
- $75M Offering amount: $75M
- Investors reported
- 20 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 15, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 30, 2018 | Initial | $74,999,990 | No comparison | 20 | SEC filing |
| May 31, 2011 | Initial | $1,113,344 | No comparison | 2 | SEC filing |
| Aug 21, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jul 25, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $4.5M (estimated)
- Finders' fees
- $0
- Form D file number
- 021-313534
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Stifel, Nicolaus & Company, Incorporated | 793 | |
| Wells Fargo Securities, LLC | 126292 | |
| Oppenheimer & Co. Inc. | 249 | |
| Suntrust Investment Services, Inc. | 17499 | |
| Laidlaw & Company (UK) Ltd. | 119037 | |
| BTIG, LLC | 122225 |
Source: Form D, filed May 30, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Charles V. Baltic Iii | Director |
| Leah Cann | Director |
| Kevan E. Clemens | Director |
| Brian G. Drazba | Executive |
| Frederick W. Driscoll | Director |
| Nicholas R. Glover | Director |
| Daniel P. Gold | Director, Executive |
| Robert D. Mass | Executive |
| Thomas C. Reynolds | Director |
| William D. Rueckert | Director |
| David M. Urso | Executive |
| Christine A. White | Director |
| Bryan Williams | Director |
| Thomas M. Zech | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
3611 Valley Centre Drive Suite 500
San Diego, CA, 92130
San Diego, CA, 92130